According to Nexien BioPharma latest financial reports the cash on hand of NXEN is $35.15K, an decrease of -69.93% to 2022. At the end of 2022 company had $116.90K cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $35.15K | -69.93% |
2022 | $116.90K | 547.96% |
2021 | $18.04K | 67.26% |
2020 | $10.79K | -92.63% |
2019 | $146.36K | - |